Navigation Links
New Evidence Supports Efficacy and Value of Smith & Nephew NPWT Products

12 Posters on Smith & Nephew NPWT to be Presented at Symposium on Advanced Wound Care

ST. PETERSBURG, Fla., April 24 /PRNewswire-FirstCall/ -- Smith & Nephew Inc's (LSE: SN; NYSE: SNN) Advanced Wound Management division announced today that nine clinical posters featuring its Negative Pressure Wound Therapy (NPWT) products will be presented at next week's Symposium on Advanced Wound Care (SAWC) and Wound Healing Society Meeting. The poster session is open from 7:30 to 9:00am on Monday, April 27, and will include a total of 15 additional posters on studies conducted with Smith & Nephew's ACTICOAT(TM), ALLEVYN(TM), IODOSORB(TM), SECURA(TM) and BIOSTEP(TM) advanced dressings.

At booth #401, Smith & Nephew will present its RENASYS EZ(TM) and RENASYS GO(TM) NPWT products as well as its VERSAJET(TM) hydrosurgery system and the full portfolio of advanced wound dressings.

"We look forward to viewing the impressive new clinical results achieved with Smith & Nephew NPWT advanced wound management products," said Robin Carlstein, Senior Vice President of Advanced Wound Devices at Smith & Nephew. "Smith & Nephew is committed to helping clinicians at every stage of wound treatment deliver the best possible care, and deliver value to their healthcare institutions. We are particularly pleased to see so many posters regarding our NPWT offerings, as they significantly deepen the solid body of clinical evidence supporting their efficacy and ease-of-use. NPWT is a critical part of our comprehensive platform for the preparation, protection and progression towards healing of advanced wounds."

The body of new NPWT data on display at SAWC includes the following posters:

  • Negative Pressure Wound Therapy as a Dressing for Split-Thickness Skin Grafts: Our Experience -- Julie A. O'Brien, MD; Genevieve B. Broderick, MD; Janice F. Lalikos, MD; Ronald Ignotz, PhD; Heather Strom, BS; and Raymond M. Dunn, MD, University of Massachusetts.
  • An Evaluation of the Introduction of an Alternative Negative Pressure Wound Therapy -- Theresa A. Hurd, RN, MScN, MSN (Community Health Nursing) Med ACNP, Canadian Health System.
  • Negative Pressure, Positive Energy: Wound Closure Without Pain -- Use of Negative Pressure Wound Therapy Over Matrix Regeneration Grafts -- Estelle A. Zanotti, RN, MSN, APN-CNS, CWOCN, CRRN, and Dr. Robert Rosenbloom, MD, FACS, St. Alexius Medical Center, Hoffman Estates, Illinois.
  • Management of Four Patients with Complicated Entercutaneous Fistula using Pouching System in Conjunction with Negative Pressure Therapy in a Long Term Acute Care Facility (LTAC) -- Anne Blevins, BSN, RN, WCC, Clinical Coordinator, Advanced Wound Care Team, Drake Center, Health Alliance of Greater Cincinnati.
  • Negative Pressure Wound Therapy for Fistula Management - Marc Gottlieb, MD; Judy Madura, RD, RN, DWOCN; Wendy Murphy, RN, BSN; Brenda Leon, RN, BSN; Sue Kennel, RN, BSN, CWCN; Dana Altman, RN, Banner Good Samaritan Medical Center, Wound Care Program, Phoenix, Arizona.

The 22nd Annual SAWC/WHS Spring Meeting is the largest gathering of multidisciplinary wound care clinicians in the United States. It will be held from Sunday, April 26th to Wednesday, April 29th at the Gaylord Texan Resort near Dallas.

For more information about Smith & Nephew, please go to Product-specific information is available at,,,,, and

About Smith & Nephew

Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were $3.8 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

SOURCE Smith & Nephew Inc
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
2. First evidence for DNA-based vaccination against chronic hepatitis C
3. Health-care reform should start with paying evidence-based financial incentives to doctors
4. ASAP Systems now Offers Flexible Payment Options for its Barcode Inventory, Asset and Evidence Tracking Solutions Through a Strategic Microsoft Financing™ Partnership
5. Designing the Care-Planning Process to Guide Evidence-Based Practice
6. More compelling evidence on why earlier HIV treatment lengthens survival
7. Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009
8. The Compelling Evidence-Based Case for Hospital IT Investments: Complimentary Webinar
9. Kaiser Permanente Data Provides Strong Evidence for Continued Value of Combined Pap and HPV Testing
10. MEDai Enhances Chronic Care Management with Real-Time, Evidence-Based Medicine Guideline Analysis
11. American Dental Association Launches Evidence-Based Dentistry Web Site
Post Your Comments:
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... The McHenry ... a recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. ... v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - Today, ... in both surgical and non-surgical treatments, announced the expansion of his private practice ... Surgery. , Highly trained and nationally recognized for his natural approach, Dr. ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology: